Heparin in Interventional Radiology: A Therapy in Evolution
Authors:
- 28 June 2005
- journal article
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 22 (02) , 95-107
Abstract
Interventional radiology techniques made possible by the antithrombotic properties of heparin have revolutionized treatment for a myriad of disorders. Newer low-molecular-weight heparins (LMWHs) offer several advantages over unfractionated heparin (UFH), especially in chronic settings. They are increasing in popularity for use during vascular procedures. However, LMWH shares limitations with UFH such as heterogeneity, nonspecificity, and induction of thrombocytopenia. These drawbacks have led to a search for the next generation of antithrombotic agents. Homogeneous drugs targeting specific coagulation cascade molecules are now available. The number of alternative anticoagulant drug combinations presents clinicians with a confusing array of choices. The strengths and weaknesses of UFH, LMWH, and direct antithrombin agents are presented. The promising future of LMWH and hirudins is discussed.Keywords
This publication has 100 references indexed in Scilit:
- EnoxaparinDrugs, 2002
- BivalirudinDrugs, 2002
- Minimal heparinization in coronary angioplasty—how much heparin is really warranted?The American Journal of Cardiology, 2000
- Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)JACC, 1996
- Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patientsAmerican Heart Journal, 1996
- Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trialJACC, 1994
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.Circulation, 1984
- Inhibition of Thrombin Induced Aggregation of Human Platelets by HeparinScandinavian Journal of Haematology, 1971